Vitamin D deficiency deteriorated MASLD progression through the activation of toll-like receptor 2 (TLR2) and TLR4 through the CD14/human LPS-binding protein (LBP), subsequently triggering downstream inflammatory signaling molecules that result in steatosis and inflammation [66] (Figure 2). The gene discussed is TLR2; the disease is steatosis.